Medical Discoveries | Pharma Voice | Experimental | Safety Innovations | Certifications & Approvals | Laboratories
Johnson & Johnson told to throw out 60M COVID-19 shots made at troubled Emergent site: report
Bayer to spend $300M on production expansion in Finland, eying robotics, automation and more
Bayer pledges $300M to boost production in world’s ‘contraceptive capital’
Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream
Lilly’s internal probe into Branchburg plant found company didn’t mislead FDA, but DOJ investigation remains: report
Lilly’s internal probe into Branchburg, New Jersey, plant found company didn’t mislead FDA, but DOJ investigation remains: report
Fierce Pharma Asia—Biogen, Eisai’s Alzheimer’s nod; Stemirna’s $188M mRNA vaccine raise; the first China-made HER2 ADC
Fierce Pharma Asia—Biogen, Eisai’s Alzheimer’s nod; Stemirna’s $188M mRNA vaccine raise; China-made HER2 ADC
GSK reveals 26M Americans skipped routine vaccinations last year, quantifying widely held suspicions
GSK reveals 26 million Americans skipped routine vaccinations last year, quantifying widely held suspicions
Coinciding with Global Wellness Day (celebrated on second Saturday of June every year), Heartfulness group of organizations has launched “Healthcare by Heartfulness” Covid Care app to provide covid consultation and
COVID-19 came as a shock to the Indian economy. A phase that the country was not prepared for in the beginning and with the unexpected
The manufacturing debacle at Emergent BioSolutions’ Baltimore plant keeps getting worse. After spending weeks inspecting the site, the FDA has instructed COVID-19 vaccine maker Johnson &
Bayer, currently in the midst of a gung-ho cell therapy expansion in the U.S., is turning its attention back to Europe as it looks to
Bayer, currently in the midst of a gung-ho cell therapy expansion in the U.S., is turning its attention back to Europe as it looks to
Despite back-to-back phase 3 trial wins in atopic dermatitis, Incyte’s ruxolitinib cream isn’t immune to class-wide JAK inhibitor safety scrutiny. Incyte on Friday disclosed that the FDA has put off
When Eli Lilly last month revealed that the U.S. Justice Department issued a subpoena into its manufacturing facility in Branchburg, New Jersey, the drugmaker’s own independent
When Eli Lilly last month revealed that the U.S. Justice Department issued a subpoena into its manufacturing facility in Branchburg, New Jersey, the drugmaker’s own independent
Portland, OR: In honor of Allergy and Asthma Awareness Month, digital health firm Vivacare announced today the launch of its new Asthma Education program developed in collaboration
Stirred – a new hybrid healthcare agency – has been launched this week by former senior Pegasus colleagues Jo Spadaccino and Stuart Hehir. Between them,
